These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7900238)

  • 21. The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.
    Jeon SH; Chang SG; Kim JI
    Anticancer Res; 1999; 19(6C):5593-7. PubMed ID: 10697624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
    Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
    Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC
    Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic renal cell carcinoma.
    Flanigan RC; Campbell SC; Clark JI; Picken MM
    Curr Treat Options Oncol; 2003 Oct; 4(5):385-90. PubMed ID: 12941198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy.
    Ljungberg B; Landberg G; Alamdari FI
    Scand J Urol Nephrol; 2000 Aug; 34(4):246-51. PubMed ID: 11095082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.
    Naito S; Kimiya K; Sakamoto N; Soejima T; Ueda T; Kumazawa J; Osada Y; Kurozumi T; Sagiyama K; Ariyoshi A
    Urology; 1991 Feb; 37(2):95-9. PubMed ID: 1992596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era.
    Pal SK; Nelson RA; Vogelzang N
    PLoS One; 2013; 8(5):e63341. PubMed ID: 23658823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does radical nephrectomy with immunochemotherapy have any superiority over embolization alone in metastatic renal cell carcinoma? A preliminary report.
    Demirci D; Tatlişen A; Ekmekçioğlu O; Ozcan N; Kaya R
    Urol Int; 2004; 73(1):54-8. PubMed ID: 15263794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy.
    Kim SH; Kim JK; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
    Oncotarget; 2017 Jul; 8(30):49615-49624. PubMed ID: 28548948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic renal cell carcinoma risk according to tumor size.
    Thompson RH; Hill JR; Babayev Y; Cronin A; Kaag M; Kundu S; Bernstein M; Coleman J; Dalbagni G; Touijer K; Russo P
    J Urol; 2009 Jul; 182(1):41-5. PubMed ID: 19450840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
    Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
    J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
    Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
    World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
    Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
    PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
    Han KR; Pantuck AJ; Bui MH; Shvarts O; Freitas DG; Zisman A; Leibovich BC; Dorey FJ; Gitlitz BJ; Figlin RA; Belldegrun AS
    Urology; 2003 Feb; 61(2):314-9. PubMed ID: 12597937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of brain metastasis of renal cell carcinoma.
    Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
    Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
    Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
    Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Ku JH
    Tumori; 2007; 93(1):68-74. PubMed ID: 17455874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
    Motzer RJ; Mazumdar M; Bacik J; Berg W; Amsterdam A; Ferrara J
    J Clin Oncol; 1999 Aug; 17(8):2530-40. PubMed ID: 10561319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-modal treatment for metastatic renal cancer: the role of surgery.
    Russo P
    World J Urol; 2010 Jun; 28(3):295-301. PubMed ID: 20364382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.